Faegre Baker Daniels advised Endocyte, Inc. on its $86.2 million shelf-takedown offering of 20,535,714 shares of common stock, which includes full exercise of the underwriters’ greenshoe…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
